2026年6月最新影响因子数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎反馈给我们。
| 热门AI工具: |
论文引言生成
New
AI 写作痕迹检测
Hot
学术改写降重
论文摘要生成
参考文献挖掘工具
审稿意见辅助撰写
|
查看更多AI工具 >> |
| 近期推荐: | 热 Wiley 2026暑期线上学习营 | 报名正式开启! | 新 Springer Nature生物医学与生命科学资源合集 | 附免费书单 | 热 全流程投稿协助套餐服务 |
| |
| 基本信息 | 登录收藏 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字![]() | Molecular and Clinical Oncology MOL CLIN ONCOL (此期刊被最新的JCR期刊ESCI收录) LetPub评分 4.0
50人评分
我要评分
声誉 5.2 影响力 2.5 速度 7.0 | |||||||||||||||||||||
| 期刊ISSN | 2049-9450 | 安装APP,查看期刊最新消息
| ||||||||||||||||||||
| E-ISSN | 2049-9469 | |||||||||||||||||||||
| 2025-2026最新IF (数据来源于网友提供) | 注册或登录后,查看IF | |||||||||||||||||||||
| 实时影响因子 | - | |||||||||||||||||||||
| 2025-2026自引率 | 0.0%点击查看自引率趋势图 | |||||||||||||||||||||
| 五年IF (数据来源于网友提供) | 1.603数据由网友[等待deer]收集提供 | |||||||||||||||||||||
| h-index | 暂无h-index数据 | |||||||||||||||||||||
| CiteScore ( 2026年6月最新版) |
| |||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||
| 期刊官方网站 | ||||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||
| 期刊投稿网址 | ||||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Comparative efficacy and safety of first-line treatments for RAS wild-type metastatic colorectal cancer: A systematic review and network meta-analysis Author: Wu, Songke; Wang, Chengshi; Liu, Shuyun Journal: MOLECULAR AND CLINICAL ONCOLOGY. 2026; Vol. 25, Issue 2, pp. -. DOI: 10.3892/mco.2026.2960 Icariin: Multi-target natural products for the multi-stage prevention and treatment of breast cancer (Review) Author: Wen, Yu; Chen, Yunyan; Yang, Lei; Wu, Tingfen; Peng, Qinghua; Xie, Huiyan; Chen, Xuemei Journal: MOLECULAR AND CLINICAL ONCOLOGY. 2026; Vol. 25, Issue 1, pp. -. DOI: 10.3892/mco.2026.2954 Exploring the value of the ovarian-adnexal reporting and data system combined with tumor markers in the differential diagnosis of benign and malignant ovarian-adnexal tumors Author: Zhang, Liyan; Xiao, Li; Wang, Jiaxing; Wang, Haiyan Journal: MOLECULAR AND CLINICAL ONCOLOGY. 2026; Vol. 24, Issue 6, pp. -. DOI: 10.3892/mco.2026.2952 Crosstalk between immune and programmed cell death and their application in colorectal cancer risk stratification Author: Wu, Chaoqun; Cai, Yueshuang; Chen, Shao; Huang, Yuelian; Wu, Qiumei Journal: MOLECULAR AND CLINICAL ONCOLOGY. 2026; Vol. 24, Issue 6, pp. -. DOI: 10.3892/mco.2026.2951 | |||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Molecular and Clinical Oncology的语言要求,还能让Molecular and Clinical Oncology编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Molecular and Clinical Oncology编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||
| 通讯方式 | ||||||||||||||||||||||
| 出版商 | Spandidos Publications UK | |||||||||||||||||||||
| 涉及的研究方向 | ONCOLOGY- | |||||||||||||||||||||
| 出版国家或地区 | ||||||||||||||||||||||
| 出版语言 | ||||||||||||||||||||||
| 出版周期 | ||||||||||||||||||||||
| 出版年份 | 0 | |||||||||||||||||||||
| 年文章数 | 114点击查看年文章数趋势图 | |||||||||||||||||||||
| Gold OA文章占比 | 99.68% | |||||||||||||||||||||
| 研究类文章占比: 文章 ÷(文章 + 综述) | 75.44% | |||||||||||||||||||||
| WOS期刊JCR分区 ( 2025-2026年最新版) | 注册或登录后,查看WOS分区等级 | |||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版:不在预警名单中 2025年03月发布的2025版:不在预警名单中 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||
| 《新锐期刊分区表》 ( 2026年3月发布) | 点击查看期刊分区表趋势图
| |||||||||||||||||||||
| 期刊分区表 ( 2025年3月升级版) |
| |||||||||||||||||||||
| 期刊分区表 ( 2023年12月旧的升级版) | (没有被旧的期刊分区表收录,仅供参考) | |||||||||||||||||||||
| SCI期刊收录coverage | Emerging Sources Citation Index (ESCI) Scopus (CiteScore) | |||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2049-9450%5BISSN%5D | |||||||||||||||||||||
| 平均审稿速度 | 网友分享经验: | |||||||||||||||||||||
| 平均录用比例 | 网友分享经验: | |||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在Molecular and Clinical Oncology顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Comparative efficacy and safety of first-line treatments for RAS wild-type metastatic colorectal cancer: A systematic review and network meta-analysis Author: Wu, Songke; Wang, Chengshi; Liu, Shuyun Journal: MOLECULAR AND CLINICAL ONCOLOGY. 2026; Vol. 25, Issue 2, pp. -. DOI: 10.3892/mco.2026.2960 PubMed DOI |
| 2. | Icariin: Multi-target natural products for the multi-stage prevention and treatment of breast cancer (Review) Author: Wen, Yu; Chen, Yunyan; Yang, Lei; Wu, Tingfen; Peng, Qinghua; Xie, Huiyan; Chen, Xuemei Journal: MOLECULAR AND CLINICAL ONCOLOGY. 2026; Vol. 25, Issue 1, pp. -. DOI: 10.3892/mco.2026.2954 PubMed DOI |
| 3. | Exploring the value of the ovarian-adnexal reporting and data system combined with tumor markers in the differential diagnosis of benign and malignant ovarian-adnexal tumors Author: Zhang, Liyan; Xiao, Li; Wang, Jiaxing; Wang, Haiyan Journal: MOLECULAR AND CLINICAL ONCOLOGY. 2026; Vol. 24, Issue 6, pp. -. DOI: 10.3892/mco.2026.2952 PubMed DOI |
| 4. | Crosstalk between immune and programmed cell death and their application in colorectal cancer risk stratification Author: Wu, Chaoqun; Cai, Yueshuang; Chen, Shao; Huang, Yuelian; Wu, Qiumei Journal: MOLECULAR AND CLINICAL ONCOLOGY. 2026; Vol. 24, Issue 6, pp. -. DOI: 10.3892/mco.2026.2951 PubMed DOI |
| 5. | Research advances in the role of circulating microorganisms in gastrointestinal tumors (Review) Author: Yang, Yang; Ren, Yingzheng; Ma, Tian; An, Junjie; Jin, Shuai; Dong, Yonghong Journal: MOLECULAR AND CLINICAL ONCOLOGY. 2026; Vol. 24, Issue 6, pp. -. DOI: 10.3892/mco.2026.2949 PubMed DOI |
| 6. | Advances in the molecular mechanisms and clinical applications of LEMD1 in tumor development and progression (Review) Author: Wang, Xiao-Bo; Wang, Xian-Fei; Karim, Sairah Binti Abdul Journal: MOLECULAR AND CLINICAL ONCOLOGY. 2026; Vol. 24, Issue 6, pp. -. DOI: 10.3892/mco.2026.2948 PubMed DOI |
| 7. | A cascade via CD276/PI3K/SIRT1/E-Cad in overcoming contact inhibition of proliferation in hepatocellular carcinoma cells Author: Yu, Xiaobo; Su, Rong; Cao, Guoqiang; Xie, Haiyang; Zhou, Lin; Zheng, Shusen Journal: MOLECULAR AND CLINICAL ONCOLOGY. 2026; Vol. 24, Issue 5, pp. -. DOI: 10.3892/mco.2026.2941 PubMed DOI |
| 8. | Long non-coding RNAs affect the metastasis of hepatocellular carcinoma cells by regulating the epithelial-to-mesenchymal transition Author: Deng, Qiaomei; Zhou, Jilu; Zhou, Yanxi; Lao, Xiaoxia; Ma, Qingwei; Gan, Tian; Ma, Liping Journal: MOLECULAR AND CLINICAL ONCOLOGY. 2026; Vol. 24, Issue 5, pp. -. DOI: 10.3892/mco.2026.2940 PubMed DOI |
| 9. | Multi-omics analysis reveals psoralen to suppresses renal cell carcinoma through the PI3K/AKT pathway Author: Chen, Di; Chen, Tingting; Yang, Yuru; Wang, Andong Journal: MOLECULAR AND CLINICAL ONCOLOGY. 2026; Vol. 24, Issue 5, pp. -. DOI: 10.3892/mco.2026.2942 PubMed DOI |
| 10. | Unveiling the mysteries of C1QBP in gynecological tumors (Review) Author: Zhang, Hanrui; Feng, Jia; Zhu, Xidan; Fu, Fuyou; Li, Baolin; Guo, Tongtong; Liu, Jinbo; Zhan, Ping Journal: MOLECULAR AND CLINICAL ONCOLOGY. 2026; Vol. 24, Issue 5, pp. -. DOI: 10.3892/mco.2026.2944 PubMed DOI |
|
|
|
投稿状态统计: 我要评分: | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范?试试稿件自查工具,一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验:共0条 |
||||||||||||||||
|
|

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号:沪ICP备10217908号-1
沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室